首页> 外文期刊>American Journal of Perinatology Reports >Neonatal Thrombocytopenia as a Consequence of Maternal Preeclampsia
【24h】

Neonatal Thrombocytopenia as a Consequence of Maternal Preeclampsia

机译:新生儿血小板减少症是母体先兆子痫的后果

获取原文
           

摘要

Introduction Preeclampsia (preE) is pregnancy-induced hypertension affecting a significant proportion of pregnant women worldwide and can cause detrimental effects in the mother and newborn. Some of the effects in the newborn include neonatal thrombocytopenia. Pertaining specifically to neonatal thrombocytopenia, several questions remain unanswered. Discussion According to the current literature, neonatal thrombocytopenia due to maternal preE is highly prevalent in the general population and the incidence is reported to be around 30% worldwide. This review gives an insight into the syndrome and summarizes the possible pathological mechanisms, the diagnostic approach, complications, and therapeutic interventions of neonatal thrombocytopenia. It also identifies the involvement of other cell lines, apart from platelets in the newborns. Furthermore, we suggest a future prospective study to investigate the pathogenesis of preE and plan a study involving animal models to come up with a possible therapeutic intervention to prevent preE and its various consequences in neonates.
机译:引言先兆子痫(preE)是由妊娠引起的高血压,影响全世界相当大比例的孕妇,并可能对母亲和新生儿造成不利影响。对新生儿的某些影响包括新生儿血小板减少症。与新生儿血小板减少症特别相关的几个问题仍未得到解答。讨论根据目前的文献,由于母体preE引起的新生儿血小板减少症在普通人群中非常普遍,据报道全世界的发病率约为30%。这篇综述提供了对该综合征的见解,并总结了新生儿血小板减少症的可能病理机制,诊断方法,并发症和治疗干预措施。它也鉴定了除新生儿血小板外其他细胞系的参与。此外,我们建议未来进行前瞻性研究,以调查preE的发病机理,并计划一项涉及动物模型的研究,以提出可能的治疗干预措施,以预防preE及其在新生儿中的各种后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号